Pure Global

Sodium Hyaluronate 3% w/v with Chondroitin sulphate 4% w/v ophthalmic solution for Domestic and Export purpose - India CDSCO Medical Device Registration

Sodium Hyaluronate 3% w/v with Chondroitin sulphate 4% w/v ophthalmic solution for Domestic and Export purpose is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000225_eb8fdb64b24df48360d902d7b73f3166_d3843c2cee9e94c239c50fbc83a3d7ed. This device is marketed under the brand name -----. The license holder is AUROLAB, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Sodium Hyaluronate 3% w/v with Chondroitin sulphate 4% w/v ophthalmic solution for Domestic and Export purpose
UID: MFG/MD/2019/000225_eb8fdb64b24df48360d902d7b73f3166_d3843c2cee9e94c239c50fbc83a3d7ed

Brand Name

-----

License Holder

AUROLAB

Device Class

Class C

Approving Authority

Central Drug Standard Control Organisation, South Zone

Product Information

The medical device is indicated as surgical adjunct during surgical procedures involving the anterior chamber of the eye, including cataract extraction and insertion of intraocular lenses. It maintains the depth of the anterior chamber during the whole surgical procedure and permits greater operative precision without the risk of damaging the endothelium of the cornea or other intraocular tissues

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing